Cerebral histamine H1 receptor binding potential measured with PET under a test dose of olopatadine, an antihistamine, is reduced after repeated administration of olopatadine.

Source:http://linkedlifedata.com/resource/pubmed/id/19443589

Download in:

View as

General Info

PMID
19443589